Dermal dendrocyte ballooning.

Adult; Antimetabolites, Antineoplastic/adverse effects/blood; Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse effects; Dendritic Cells/pathology; Drug Eruptions/etiology/pathology; Humans; Keratinocytes/pathology; Methotrexate/adverse effects/blood; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Skin/pathology

Disciplines :

Dermatology

Author, co-author :

Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

English

Title :

Dermal dendrocyte ballooning.

Publication date :

2006

Journal title :

American Journal of Clinical Dermatology

ISSN :

1175-0561

eISSN :

1179-1888

Publisher :

Adis International, Auckland, New Zealand

Volume :

Issue :

Pages :

391-2

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 16 February 2009

Statistics

Number of views

40 (2 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Headington JT. The dermal dendrocyte. In: Callen JP, Dahl MV, Golitz LE, editors. Advances in dermatology. Chicago (IL): Year Book Medical Publishers, 1986: 159-71
Cerio R, Griffiths CEM, Cooper KD, et al. Characterization of factor XIIIa-positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 1989; 121: 421-31
Arrese J, Piérard GE. Factor XIIIa positive dendrocytes and the dermal microvascular unit. Dermatologica 1990; 180: 51-3
Headington JT, Cerio R. Dendritic cells and the dermis. Am J Dermatopathol 1990; 12: 217-20
Nestle FO, Zheng X, Thompson C, et al. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993; 151: 6535-45
Nestle FO, Nickoloff BJ. A fresh morphological and functional look at dermal dendritic cells. J Cutan Pathol 1995; 22: 385-93
Quatresooz P, Piérard GE. Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes. Clin Exp Dermatol 2003; 28: S27-9
Paquet P, Nikkels A, Arrese JE, et al. Macrophages and tumor necrosis factor-alpha in toxic epidermal necrolysis. Arch Dermatol 1994; 130: 605-8
Paquet P, Piérard GE. Erythema multiforme and toxic epidermal necrolysis: a comparative study. Am J Dermatopathol 1997; 19: 127-32
Hermanns-Lê T, Parquet P, Piérard-Franchimont C, et al. Regulatory function of factor XIIIa-positive dendrocytes in incipient toxic epidermal necrolysis and graft-versus reaction: a hypothesis. Dermatology 1999; 198: 184-6
Paquet P, Arrese JE, Beguin Y, et al. Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction. In: Cerio R, editor. Current topics in pathology. Vol. 94. Dermatopathology. Berlin: Springer Verlag, 2001: 65-78
Paquet P, Quatresooz P, Piérard GE. Factor XIIIa-positive dendrocytes in drug-induced toxic epidermal necrolysis (Lyell's syndrome): paradoxical activation in the skin and rarefaction in lymph nodes. Dermatology 2003; 206: 374-8
Franchimont C, Piérard GE. Cutaneous pathobiology mediated by chemotherapy. J Cutan Pathol 1980; 7: 387-93
Yokel BK, Friedman KJ, Farmer ER, et al. Cutaneous pathology following etoposide therapy. J Cutan Pathol 1987; 14: 326-30
Monteiro MR, Murphy EE, Galaria NA, et al. Cytological alterations in dermal dendrocytes in vitro: evidence for transformation to a non-dendritic phenotype. Br J Dermatol 2000; 143: 84-90
Hermanns-Lê T, Piérard GE. Factor XIIIa-positive dendrocyte rarefaction in Ehlers-Danlos syndrome, classic type. Am J Dermatopathol 2001; 23: 427-30
Quatresooz P, Hermanns-Lê T, Ciccarelli A, et al. Tensegrity and type I dermal dendrocytes in acromegaly. Eur J Clin Invest 2005; 35: 133-9